Literature DB >> 3894692

Monoclonal antibodies against transitional cell carcinoma for detection of malignant urothelial cells in bladder washing.

D K Chopin, J B deKernion, D L Rosenthal, J L Fahey.   

Abstract

The diagnosis of transitional cell carcinoma by cytological examination of exfoliated urinary cells is important in the early detection and followup of patients with this disease. Proper interpretation requires a skilled pathologist. Accuracy also is influenced by collection methods and nonmalignant pathological conditions of the bladder. An immunocytochemical technique using monoclonal antibodies G4 and E7 successfully identified tumor-associated antigens on the surface of transitional carcinoma cells obtained by bladder washings. The method, which uses immunoperoxidase staining, was compared to conventional Papanicolaou staining of bladder washings from 75 patients with and without transitional cell carcinoma. Patients were divided into 4 groups: group 1 (nontumor control)--15 patients with no pathological condition of the bladder or nonmalignant urological diseases, group 2 (nontransitional cell carcinoma)--19 patients with other urological malignancies, group 3-18 patients with active transitional cell carcinoma and group 4-23 patients with a history of transitional cell carcinoma but no evidence of tumor at the time of the washing. The incidence of positive staining in these groups was 0, 5, 78 and 0 per cent, respectively. The diagnostic value of immunoperoxidase staining was similar to that of Papanicolaou staining in the control group and in patients with high grade transitional cell carcinoma, and provided specific morphological criteria not possible by conventional cytology studies. Interpretation of immunoperoxidase staining was difficult in washings with a large number of inflammatory cells if endogenous peroxidase activity was not blocked properly. The application of the immunoperoxidase staining method for diagnosis of low grade tumor is under further investigation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3894692     DOI: 10.1016/s0022-5347(17)47118-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Clinical studies on bladder tumor-associated antigen in serum of patients with bladder cancer by using monoclonal antibody and sandwich ELISA.

Authors:  S S Zhu; Y C Zhang; R Z Hu; Z Q Ye; C J Li; Q A Lin
Journal:  J Tongji Med Univ       Date:  1990

Review 2.  Invasive bladder cancer--possible future treatment considerations.

Authors:  R A Gardiner
Journal:  Urol Res       Date:  1986

Review 3.  The role of nuclear matrix protein 22 in the detection of persistent or recurrent transitional-cell cancer of the bladder.

Authors:  S W Shelfo; M S Soloway
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

4.  Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1.

Authors:  E Anagnostaki; D Skarlos; N Tamvakis; P Psaropoulou; E Blana; A Bamias; S Legaki; G Aravantinos; C Deliveliotis; K Dimopoulos
Journal:  Br J Cancer Suppl       Date:  1990-07

5.  Use of monoclonal antibody E48 in diagnosing transitional cell carcinoma of urinary bladder.

Authors:  R Torenbeek; C E Blomjous; J J Quak; S Ybema; C J Meijer
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

6.  Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumors.

Authors:  C Cordon-Cardo; D D Wartinger; M R Melamed; W Fair; Y Fradet
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.